SuperworthNovavax shares outstanding NVAX
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 164.6M
- On a year earlier
- −7.1%
- fewer shares
Novavax had 164.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 7.1% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 187.7M | +17% |
| FY2024 | 160.2M | +30% |
| FY2023 | 123.7M | +55% |
| FY2022 | 79.8M | +5% |
| FY2021 | 75.7M | +15% |
| FY2020 | 65.7M | +134% |
| FY2019 | 28.1M | +47% |
| FY2018 | 19.2M | −94% |
| FY2017 | 316.1M | +17% |
| FY2016 | 271.2M | +1% |
| FY2015 | 269.8M | +13% |
| FY2014 | 238.5M | +14% |
| FY2013 | 208.5M | +44% |
| FY2012 | 145.1M | +26% |
| FY2011 | 115.3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 164.6M | −7% | |
| Q1 FY26 | 163.3M | −8% | |
| Q4 FY25 | 187.7M | +17% | |
| Q3 FY25 | 162.4M | +1% | |
| Q2 FY25 | 177.2M | +7% | |
| Q1 FY25 | 177.6M | +27% | |
| Q4 FY24 | 160.2M | +30% | |
| Q3 FY24 | 160M | +55% | |
| Q2 FY24 | 165.9M | +59% | |
| Q1 FY24 | 139.9M | +62% | |
| Q4 FY23 | 123.7M | +55% | |
| Q3 FY23 | 103.4M | +32% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Novavax
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.